Dopamine Hydrochloride Injection — FDA Drug Shortage

Current — Baxter Healthcare

The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Nov 6, 2017. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Baxter Healthcare
Package NDC
0338-1007-03
Dosage Form
Injection
Presentation
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)
Initial Posting
Nov 6, 2017

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.